These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3003956)

  • 1. Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets.
    Nimpf J; Gries A; Wurm H; Kostner GM
    Thromb Haemost; 1985 Dec; 54(4):824-7. PubMed ID: 3003956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of beta 2-glycoprotein-I with human blood platelets: influence upon the ADP-induced aggregation.
    Nimpf J; Wurm H; Kostner GM
    Thromb Haemost; 1985 Aug; 54(2):397-401. PubMed ID: 4082080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of anti-platelet activity of Oligoporus tephroleucus oligoporin A: involvement of extracellular signal-regulated kinase phosphorylation and cyclic nucleotide elevation.
    Park JY; Oh WJ; Kim MJ; Kim TH; Cho JY; Park HJ; Lee IK; Kim S; Kim GS; Kim SK; Seo GS; Yun BS; Rhee MH
    Platelets; 2012; 23(5):376-85. PubMed ID: 22309049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of calcium, thrombin and nucleotides (ADP, cAMP, cGMP) on blood platelet glycolysis and energy metabolism].
    Nikulin AA
    Farmakol Toksikol; 1980; 43(5):585-90. PubMed ID: 6256208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclic 3',5'-guanosine monophosphate on human platelet function.
    Chiang TM; Dixit SN; Kang AH
    J Lab Clin Med; 1976 Aug; 88(2):215-21. PubMed ID: 182889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
    Chirkov YY; Mishra K; Chandy S; Holmes AS; Kanna R; Horowitz JD
    J Heart Valve Dis; 2006 Jan; 15(1):28-33. PubMed ID: 16480009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of neferine on platelet aggregation in rabbits].
    Yu J; Hu WS
    Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
    Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation.
    Nimpf J; Wurm H; Kostner GM
    Atherosclerosis; 1987 Feb; 63(2-3):109-14. PubMed ID: 3827975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.
    Anfossi G; Russo I; Massucco P; Mattiello L; Balbo A; Cavalot F; Trovati M
    Thromb Res; 2001 May; 102(4):319-30. PubMed ID: 11369425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats.
    Qu YZ; Li XX
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.
    Ferreira MA; do Nascimento NR; de Sousa CM; Pessoa OD; de Lemos TL; Ventura JS; Schattner M; Chudzinski-Tavassi AM
    Br J Pharmacol; 2008 Jul; 154(6):1216-24. PubMed ID: 18516074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport.
    Borgognone A; Pulcinelli FM
    Thromb Haemost; 2012 Nov; 108(5):955-62. PubMed ID: 23014861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
    Matsuoka I; Suzuki T
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
    Oda A; Druker BJ; Smith M; Salzman EW
    Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.